Responses
Cervical cancer
2022-RA-743-ESGO Improving risk stratification for cervical cancer in patients treated with concurrent chemoradiation and MRI-image guided adaptive brachytherapy in EMBRACE study: results from an international collaborative translational research study (BIOEMBRACE-I)
Compose a Response to This Article
Other responses
No responses have been published for this article.